Propofol inhibits glioma progression by regulating circMAPK4/miR-622/HOXA9 axis

Gaopeng Xiao1, Liuqiong Yu2, Wenmin Tan3

  • 1Department of Anesthesiology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, 157 Jin Bi Road, Xishan District, Kunming, 650000, Yunnan, China.

Metabolic Brain Disease
|November 3, 2022
PubMed

Insights

Propofol inhibits glioma progression by regulating the circMAPK4/miR-622/HOXA9 pathway. This mechanism involves propofol reducing circMAPK4, which in turn affects miR-622 and HOXA9 expression, ultimately suppressing tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Neuroscience

Background:

  • Propofol exhibits tumor-suppressive properties in glioma.
  • The precise molecular mechanisms underlying propofol's effects on glioma progression remain largely unelucidated.

Purpose of the Study:

  • To investigate the potential role of a circular RNA (circRNA)/microRNA (miRNA)/mRNA network in mediating propofol's effects on glioma.
  • To explore the circMAPK4/miR-622/HOXA9 axis in propofol-treated glioma cells.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction and western blot were used to determine the expression levels of circMAPK4, miR-622, and HOXA9.
  • Cell proliferation, migration, invasion, and apoptosis assays (Cell Counting Kit-8, colony formation, transwell, flow cytometry) were performed.
  • Dual-luciferase reporter assays, RNA pull-down, and RNA immunoprecipitation were employed to validate target relationships.

Main Results:

  • Propofol treatment reduced circMAPK4 expression and inhibited glioma cell proliferation, migration, and invasion, while enhancing apoptosis.
  • circMAPK4 was found to target and downregulate miR-622, and its knockdown mimicked propofol's inhibitory effects.
  • miR-622 targeted HOXA9, and propofol treatment decreased HOXA9 expression, with miR-622 overexpression suppressing glioma progression by reducing HOXA9.

Conclusions:

  • Propofol exerts its tumor-suppressive effects in glioma by regulating the circMAPK4/miR-622/HOXA9 axis.
  • This axis plays a critical role in controlling glioma cell growth, migration, invasion, and apoptosis in vitro.
  • The findings elucidate a novel molecular mechanism for propofol's anti-glioma activity.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K